Immune Control
Immune Control a Conshohocken, Pa-based drug company focused on the treatment of multiple myeloma and other immunological diseases.
Launch date
Market cap
-
Enterprise valuation
CAD62—92m (Dealroom.co estimates Jul 2005.)
Conshohocken Pennsylvania (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$11.3m | Series A | ||
N/A | Acquisition | ||
| Total Funding | CAD15.4m | ||